Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Feb;83(4):1070–1074. doi: 10.1073/pnas.83.4.1070

Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormone.

K Folkers, C Y Bowers, P F Tang, M Kubota
PMCID: PMC323012  PMID: 3081889

Abstract

Apparently, no agonist has been found that is comparable in potency to the luteinizing hormone-releasing hormone (LHRH) for release of LH and follicle-stimulating hormone (FSH) without substitutions with unnatural or D forms of natural amino acids. Of 139 known "agonist analogs" of LHRH, two were active in the range of 65%. The four LHRHs known to occur in nature involve a total of six amino acids (Tyr, His, Leu, Trp, Arg, Gln) in positions 5, 7, and 8. There are 16 possible peptides with these six amino acids in positions 5, 7, and 8, of which 4 are the known LHRHs, and 2 more were synthesized. We have synthesized the 10 new peptides and assayed 11 in vivo and in vitro, and we found not only 1 but a total of 5 that have activity equivalent to or greater than that of LHRH for the release of LH and/or FSH under at least one assay condition. These five are as follows: [His5,Trp7,Gln8]LHRH; [His5,Trp7,Leu8]LHRH; [His5,Trp7]LHRH; [Trp7]LHRH; [His5]LHRH. Two of these five agonists variably released relatively more FSH than LH. One or more of these five agonists may occur in nature and one may be follicle-stimulating hormone-releasing hormone. The two peptides with Gln8 and Leu8, if occurring in nature, may have different receptors according to radioreceptor assays and to the ratio of LH/FSH release in vivo. These structures are a basis for the design of antagonists without Arg8 toward avoiding histamine release. Complete inhibition of LH and FSH release in vivo may be induced by joint use of Arg8 and Gln8 or Leu8 antagonists. These potent agonists, related to LHRH, may be therapeutically useful in disorders of reproduction, the central nervous system, and for the control of hormone-dependent carcinomas.

Full text

PDF
1070

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowers C. Y., Humphries J., Wasiak T., Folkers K., Reynolds G. A., Reichert L. E., Jr On the inhibitory effects of luteinizing hormone-releasing hormone analogs. Endocrinology. 1980 Mar;106(3):674–683. doi: 10.1210/endo-106-3-674. [DOI] [PubMed] [Google Scholar]
  2. Conne B. S., Aubert M. L., Sizonenko P. C. Quantification of pituitary membrane receptor sites to LHRH: use of a superactive analog as tracer. Biochem Biophys Res Commun. 1979 Oct 29;90(4):1249–1256. doi: 10.1016/0006-291x(79)91171-9. [DOI] [PubMed] [Google Scholar]
  3. Coy D. H., Coy E. J., Schally A. V. Luteinizing hormone releasing hormone. Solid-phase synthesis of a 5-phenylalanine analog possessing high biological activity. J Med Chem. 1973 Jan;16(1):83–84. doi: 10.1021/jm00259a023. [DOI] [PubMed] [Google Scholar]
  4. Folkers K., Bowers C. Y., Kubiak T., Stepinski J. Antagonists of the luteinizing hormone releasing hormone with pyridyl-alanines which completely inhibit ovulation at nanogram dosage. Biochem Biophys Res Commun. 1983 Mar 29;111(3):1089–1095. doi: 10.1016/0006-291x(83)91411-0. [DOI] [PubMed] [Google Scholar]
  5. Folkers K., Bowers C. Y., Shieh H. M., Liu Y. Z., Xiao S. B., Tang P. F., Chu J. Y. Antagonists of the luteinizing hormone releasing hormone (LHRH) with emphasis on the TRP7 of the salmon and chicken II LHRH's. Biochem Biophys Res Commun. 1984 Sep 28;123(3):1221–1226. doi: 10.1016/s0006-291x(84)80263-6. [DOI] [PubMed] [Google Scholar]
  6. Heber D., Marshall J. C., Odell W. D. GnRH membrane binding: identification, specificity, and quantification in nonpituitary tissues. Am J Physiol. 1978 Aug;235(2):E227–E230. doi: 10.1152/ajpendo.1978.235.2.E227. [DOI] [PubMed] [Google Scholar]
  7. IGARASHI M., MCCANN S. M. A HYPOTHALAMIC FOLLICLE STIMULATING HORMONE-RELEASING FACTOR. Endocrinology. 1964 Mar;74:446–452. doi: 10.1210/endo-74-3-446. [DOI] [PubMed] [Google Scholar]
  8. Ling N., Vale W. Analogs of luteinizing hormone releasing factor (LRF). Synthesis and biological activity of ((Nalpha-Me)Leu-7)LRF and (D-Ala-6,(Nalpha-Me)Leu-7)LRF. Biochem Biophys Res Commun. 1975 Apr 7;63(3):801–806. doi: 10.1016/s0006-291x(75)80454-2. [DOI] [PubMed] [Google Scholar]
  9. Miyamoto K., Hasegawa Y., Nomura M., Igarashi M., Kangawa K., Matsuo H. Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3874–3878. doi: 10.1073/pnas.81.12.3874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sherwood N., Eiden L., Brownstein M., Spiess J., Rivier J., Vale W. Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A. 1983 May;80(9):2794–2798. doi: 10.1073/pnas.80.9.2794. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES